This article presents a comprehensive safety evaluation of Bifidobacterium animalis subsp. lactis BLa80, a new probiotic strain with potential applications in the food industry.

Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder characterized by infrequent bowel movements, difficult stool passage, and incomplete evacuation.

In recent years, the consumption trend of probiotic products has been increasing day by day, and the industry development has entered a boom period.

This study introduces a novel probiotic strain of Lactiplantibacillus plantarum​ CW006, with significant antihypertensive properties. The strain's ability to produce products that lower blood pressure offers promising applications in food processing and the pharmaceutical industry.

Akkermansia muciniphila​ (AKK), often referred to as the “longevity probiotic,” has garnered increasing attention for its promising role in promoting healthy aging.

Chronic kidney disease (CKD) is a significant health problem that affects millions of individuals globally. The need for effective therapeutic agents has led to the exploration of probiotics as a potential treatment. This journal focuses on a specific probiotic agent designed to improve CKD, its composition, and its applications, as described in the patent.